Last updated on October 2018

A Phase 3 STudy of CaPRe in LOwering Very hiGh TriglYcerides (TRILOGY 2)


Brief description of study

The primary objective of this study is to determine the efficacy of CaPre 4 g daily, compared to placebo, in lowering fasting TG levels in subjects with fasting TG levels 500 mg/dL and 1500 mg/dL (5.7 mmol/L and 17.0 mmol/L) after 12 weeks of treatment.

Approximately 615 subjects will be screened to obtain 245 randomized subjects following a treatment allocation ratio of 2.5:1 (CaPre:placebo).

Clinical Study Identifier: NCT03361501

Find a site near you

Start Over

Research site

Coral Gables, FL United States
  Connect »

Research site

Wauconda, IL United States
  Connect »

Research Site

Las Vegas, NV United States
  Connect »

Research site

Clearwater, FL United States
  Connect »

Research site

Fort Lauderdale, FL United States
  Connect »

Research site

Miami Lakes, FL United States
  Connect »

Research site

Miami, FL United States
  Connect »

Research site

Savannah, GA United States
  Connect »

Research site

Las Vegas, NV United States
  Connect »

Research site

Summerville, SC United States
  Connect »

Research site

Birmingham, AL United States
  Connect »

Research site

Childersburg, AL United States
  Connect »

Research site

Thousand Oaks, CA United States
  Connect »

Research site

Monument, CO United States
  Connect »

Research site

Jacksonville, FL United States
  Connect »

Research site

Peachtree Corners, GA United States
  Connect »

Research site

Boise, ID United States
  Connect »

Research site

Norfolk, NE United States
  Connect »

Research site

New Windsor, NY United States
  Connect »

Research site

Morganton, NC United States
  Connect »

Research site

Marion, OH United States
  Connect »

Research site

Lansdale, PA United States
  Connect »

Research site

Georgetown, TX United States
  Connect »

Research site

Houston, TX United States
  Connect »

Research site

Encino, CA United States
  Connect »

Research site

Long Beach, CA United States
  Connect »

Research site

San Diego, CA United States
  Connect »

Research site

Torrance, CA United States
  Connect »

Research site

DeLand, FL United States
  Connect »

Research site

Dunwoody, GA United States
  Connect »

Research site

Iowa City, IA United States
  Connect »

Research site

Overland Park, KS United States
  Connect »

Research site

Biddeford, ME United States
  Connect »

Research site

Baltimore, MD United States
  Connect »

Research site

Hyattsville, MD United States
  Connect »

Research site

Flint, MI United States
  Connect »

Research site

Tupelo, MS United States
  Connect »

Research site

Albany, NY United States
  Connect »

Research site

Bronx, NY United States
  Connect »

Research site

Laurelton, NY United States
  Connect »

Research site

New York, NY United States
  Connect »

Research site

Oklahoma City, OK United States
  Connect »

Research site

Gaffney, SC United States
  Connect »

Research site

Union, SC United States
  Connect »

Research site

Kerrville, TX United States
  Connect »

Research site

Clinton, UT United States
  Connect »

Research site

Ogden, UT United States
  Connect »

Research site

Manassas, VA United States
  Connect »

Research site

Winnipeg, MB Canada
  Connect »

Research site

Halifax, NS Canada
  Connect »

Research site

Brampton, ON Canada
  Connect »

Research site

Burlington, ON Canada
  Connect »

Research site

London, ON Canada
  Connect »

Research site

Newmarket, ON Canada
  Connect »

Research site

Sarnia, ON Canada
  Connect »

Research site

Québec, QC Canada
  Connect »

Research site

Sherbrooke, QC Canada
  Connect »

Research site

Ciudad de mexico, Mexico
  Connect »

Research site

Culiacán, Mexico
  Connect »

Research site

Aguascalientes, Mexico
  Connect »

Research site

Chihuahua, Mexico
  Connect »

Research site

Mexico City, Mexico
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.